In silico gene expression profiling in Cannabis sativa

Abstract

The cannabis plant and its active ingredients (i.e., cannabinoids and terpenoids) have been socially stigmatized for half a century. Luckily, with more than 430,000 published scientific papers and about 600 ongoing and completed clinical trials, nowadays cannabis is employed for the treatment of many different medical conditions. Nevertheless, even if a… (More)
DOI: 10.12688/f1000research.10631.1

Topics

2 Figures and Tables

Cite this paper

@inproceedings{Massimino2017IS, title={ In silico gene expression profiling in Cannabis sativa }, author={Luca Massimino and Sergio Esposito and Gea Guerriero}, booktitle={F1000Research}, year={2017} }